Form 10-Q Biostar Pharmaceuticals, For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Biostar Pharmaceuticals (BSPM) Swings to Q2 Profit
August 14, 2014 9:15 AM EDTBiostar Pharmaceuticals (NASDAQ: BSPM) reported Q2 EPS of $0.11, versus ($0.06) reported last year. Revenue for the quarter came in at $19.2 million, versus $14.65 million reported last year.
For earnings history and earnings-related data on Biostar Pharmaceuticals (BSPM) click here.
... More